Literature DB >> 366791

Evidence that calcium regulates platelet function.

T C Detwiler, I F Charo, R D Feinman.   

Abstract

It is generally believed that calcium ions play a key role in regulation of platelet function. This is based on 3 types of evidence. 1. Analogies with other cells. Calcium ions are known to trigger secretion and contraction in many cells, possibly reflecting a general role for calcium in all secretion and contraction. 2. Indirect evidence. Platelet aggregation and secretion are induced by divalent cation ionophores. The response to the ionophore A23187 is identical to that induced by other potent stimuli. 3. Direct evidence. Platelet activation can be blocked by drugs (e. g. certain local anesthetics) that block release of calcium ions from sarcoplasmic reticulum; the inhibition can be overcome by addition of extracellular calcium in the presence of a calcium ionophore. While this does not constitute definitive proof, the central role for calcium ions remains an attractive hypothesis that justifies attempts to further define calcium pools and fluxes in platelets.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 366791

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  18 in total

1.  Platelet heterogeneity and dense tubular system changes on activation.

Authors:  R Yarom; G Lijovetzky; Y Havivi
Journal:  Experientia       Date:  1981-01-15

2.  Inhibition of 5-hydroxytryptamine-induced and -amplified human platelet aggregation by ketanserin (R 41,468), a selective 5-HT2-receptor antagonist. 1982.

Authors:  F de Clerck; J L David; P A Janssen
Journal:  Agents Actions       Date:  1994-12

3.  Aggregation, membrane potential, and transport in platelets of spontaneously hypertensive rats.

Authors:  G M Kravtsov; S N Orlov; Y V Postnov
Journal:  Pflugers Arch       Date:  1984-11       Impact factor: 3.657

4.  Reorientation of prostaglandin endoperoxide metabolism by a thromboxane synthetase inhibitor: in vitro and clinical observations.

Authors:  J Vermylen; H Deckmyn
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

5.  Defective platelet aggregation to the calcium ionophore A23187 in a patient with a lifelong bleeding disorder.

Authors:  S J Machin; J P Keenan; B A McVerry
Journal:  J Clin Pathol       Date:  1983-10       Impact factor: 3.411

6.  Studies of platelets with heavy metal impregnation techniques.

Authors:  R Yarom; R More; Y Havivi; G Lijovetzky; S Meyer
Journal:  Histochem J       Date:  1982-01

Review 7.  Diltiazem. A review of its pharmacological properties and therapeutic efficacy.

Authors:  M Chaffman; R N Brogden
Journal:  Drugs       Date:  1985-05       Impact factor: 9.546

8.  Relationship between structure of phenothiazine analogues and their activity on platelet calcium fluxes.

Authors:  J Enouf; S Lévy-Toledano
Journal:  Br J Pharmacol       Date:  1984-03       Impact factor: 8.739

9.  Role of calmodulin in platelet aggregation. Structure-activity relationship of calmodulin antagonists.

Authors:  M Nishikawa; H Hidaka
Journal:  J Clin Invest       Date:  1982-06       Impact factor: 14.808

10.  In vitro and in vivo evidence that thrombospondin-1 (TSP-1) contributes to stirring- and shear-dependent activation of platelet-derived TGF-beta1.

Authors:  Jasimuddin Ahamed; Christin A Janczak; Knut M Wittkowski; Barry S Coller
Journal:  PLoS One       Date:  2009-08-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.